Myeloid leukemia: Difference between revisions
Jump to navigation
Jump to search
Line 31: | Line 31: | ||
==[[Myeloid leukemia epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Myeloid leukemia epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Myeloid leukemia | ==[[Myeloid leukemia risk factors|Risk Factors]]== | ||
==[[Myeloid leukemia screening|Screening]]== | ==[[Myeloid leukemia screening|Screening]]== |
Revision as of 04:07, 18 September 2012
For patient information, click here
Myeloid leukemia | |
Blood smear from a patient with untreated CML showing segmented neutrophils, myelocytes, a promyelocyte, and two basophils. (Wright-Giemsa stain) Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
ICD-10 | C92 |
ICD-9 | 205 |
MeSH | D007951 |
Myeloid leukemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Myeloid leukemia On the Web |
American Roentgen Ray Society Images of Myeloid leukemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myeloid Leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therpies